FIELD: cosmetology.
SUBSTANCE: invention represents a dermal filler composition comprising a vitamin C derivative, covalently conjugated to a componentt of hyaluronic acid with a conjugation degree of at least 3 moll. %, wherein the component of hyaluronic acid is hyaluronic acid crosslinked with the diglycidyl ether of 1,4-butanediol, and hyaluronic acid has an average molecular weight of less than 1000000 Da and wherein the vitamin C derivative is selected from the group consisting of 2-glucoside, ascorbic acid, L-ascorbyl-3-Aminopropyl phosphate and sodium ascorbyl phosphate, wherein the noted composition is substantially optically transparent and characterised by the G' value constituting at least 25 Pa and not more than 200 Pa.
EFFECT: invention ensures absence of blueing associated with the Tyndall effect, even with superficial administration.
22 cl, 16 dwg, 1 tbl, 30 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITION OF SKIN FILLER AND TREATMENT METHOD | 2012 |
|
RU2679317C1 |
| SKIN FILLERS COMPOSITIONS | 2012 |
|
RU2638713C2 |
| DERMAL FILLER COMPOSITIONS, INCLUDING ANTIOXIDANTS | 2012 |
|
RU2740454C2 |
| HYALURONIC ACID-BASED COACERVATE HYDROGELS FOR USE IN DERMAL FILLERS | 2016 |
|
RU2750684C2 |
| HYALURONIC ACID GELS CONTAINING ANALGESIC AGENTS | 2009 |
|
RU2496474C2 |
| STABILIZED HYALURONIC ACID | 2019 |
|
RU2805502C2 |
| DERMAL FILLERS COMPOSITIONS, INCLUDING ANTIOXIDANTS | 2012 |
|
RU2624239C2 |
| HYALURONIC ACID GELS CONTAINING ANALGESIC AGENTS | 2009 |
|
RU2496473C2 |
| CROSS-LINKED POLYSACCHARIDE COMPOSITIONS IN SITU AND VERSIONS OF THEIR USE | 2016 |
|
RU2734419C2 |
| IMPLANTS FOR SCULPTING, AUGMENTING OR CORRECTING FACIAL FEATURES SUCH AS CHIN | 2016 |
|
RU2715234C2 |
